Nitric oxide (NO) is an endogenous vasoactive compound that contributes to pulmonary vascular homeostasis and is produced by three nitric oxide synthase (NOS) isoforms - neuronal NOS (nNOS); inducible NOS (iNOS); and endothelial NOS (eNOS) - all three of which are present in the lung. Studies using pharmacological inhibitors or knockout mice have shown that eNOS-derived NO plays an important role in modulating pulmonary vascular tone and attenuating pulmonary hypertension. However, studies focusing on the role of iNOS have shown that this isoform contributes to the pathophysiology of acute lung injury and acute respiratory distress syndrome. This review aimed at outlining the role played by NO in the control of the pulmonary circulation, both under physiological and pathophysiological conditions. In addition, we review the evidence that the L-arginine-NO-cyclic guanosine monophosphate pathway is a major pharmacological target in the treatment of pulmonary vascular diseases.
CITATION STYLE
Dias, C. A., Cau, S. B. D. A., & Tanus-Santos, J. E. (2008, June). Papel do óxido nítrico na regulação da circulação pulmonar: Implicações fisiológicas, fisiopatológicas e terapêuticas. Jornal Brasileiro de Pneumologia. https://doi.org/10.1590/S1806-37132008000600012
Mendeley helps you to discover research relevant for your work.